SYBX · Synlogic, Inc.
$1.12
+0.40 (+55.56%)
At close · Jul 29
Market Cap
$13.10M
Shares
11.70M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$1.01M
+95.7%
FY2025
Operating Margin
-511875%
-510238.7pp
FY2024
Diluted EPS
-$0.08
+95.8%
FY2025
Operating Cash Flow
-$4.36M
+86.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $8000 | $3.37M | $1.18M | $1.75M | $545K | $2.22M | $2.52M | $2.44M | — | — | |
| — | $43K | $9.15M | $43.97M | $52.04M | $47.13M | $47.47M | $41.91M | $38.03M | $30.34M | $13.93M | $18.95M | |
| $3.72M | $3.49M | $6.63M | $14.56M | $16.56M | $15.39M | $13.54M | $14.73M | $15.72M | $12.93M | $8.12M | $6.08M | |
| — | — | — | — | — | — | — | — | — | — | $159K | $54K | |
| $642K | $476K | $25.17M | — | — | — | — | — | — | — | $3.04M | — | |
| $4.43M | $4.01M | $40.96M | $58.53M | $68.6M | $62.52M | $61.01M | $56.63M | $53.75M | $43.27M | $26.62M | $25.03M | |
| -$4.43M | -$4.01M | -$40.95M | -$55.16M | -$67.42M | -$60.77M | -$60.47M | -$54.41M | -$51.23M | -$40.82M | — | — | |
| — | — | -511875% | -1636.34% | -5713.47% | -3464.37% | -11094.68% | -2446.45% | -2032.94% | -1670.38% | — | — | |
| — | — | $0 | $1000 | $2000 | $2000 | $6000 | $21K | $43K | $57K | — | — | |
| $356K | — | — | — | — | — | — | — | — | — | $350K | $44K | |
| $3.79M | $3M | $17.6M | -$2.11M | $1.27M | $204K | $1.29M | $3.04M | $2.8M | $447K | $88K | $44K | |
| — | -$1.01M | -$23.35M | -$57.27M | — | — | — | — | — | — | — | — | |
| — | $0 | $5000 | $14K | $0 | $0 | $0 | $0 | — | — | $0 | $0 | |
| -$641K | -$1.01M | -$23.36M | -$57.28M | -$66.15M | -$60.56M | -$59.17M | -$51.37M | -$48.44M | -$40.38M | -$26.27M | -$24.98M | |
| — | — | -291987.5% | -1699.26% | -5605.68% | -3452.74% | -10857.43% | -2309.94% | -1922.02% | -1652.09% | — | — | |
| -$27.86M | — | — | — | — | — | — | — | — | — | -$26.27M | -$29.3M | |
| -$641K | -$1.01M | -$23.37M | -$57.12M | -$66.26M | -$60.62M | -$59.27M | -$51.2M | -$48.49M | -$40.39M | -$26.27M | — | |
| USD/shares | — | -$0.08 | -$1.92 | -$8.81 | -$0.92 | — | — | — | — | — | — | — |
| USD/shares | — | -$0.08 | -$1.92 | -$8.81 | -$0.92 | — | — | — | — | — | — | — |
| shares | — | 12.31M | 12.2M | 6.5M | 71.73M | 55.33M | 35.84M | 30.28M | 23.88M | 6.72M | 20.83M | 5.01M |
| shares | — | 12.31M | 12.2M | 6.5M | 71.73M | 55.33M | 35.84M | 30.28M | 23.88M | 6.72M | 20.83M | 5.01M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.04×
Peer medians compare against the 213 similar-size Biotechnology companies (of 522 listed).